• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA six3os1可诊断急性中风,预测疾病严重程度,并预测中风后认知障碍。

lncRNA six3os1 diagnoses acute stroke, predicts disease severity, and predicts post-stroke cognitive impairment.

作者信息

Liu Yan, Wang Rui, Zeng Junsheng, Zhao Wei, Xiao Yanqiao, Jiang Heng, Wang Te

机构信息

Department of Neurology, The Affiliated Changsha Central Hospital, University of South China, No. 161 Shaoshan South Road, Changsha, 410004, Hunan, China.

Department of Neurology, Liaocheng People's Hospital, Liaocheng, 252000, Shandong, China.

出版信息

BMC Neurol. 2024 Dec 26;24(1):491. doi: 10.1186/s12883-024-04003-5.

DOI:10.1186/s12883-024-04003-5
PMID:39722013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11670514/
Abstract

BACKGROUND

Stroke is the main cause of death and disability. Post-stroke cognitive impairment (PSCI) is one of the most severe complications of stroke, which lacks effective biomarkers for its early detection.

OBJECTIVE

This study evaluated the significance of lncRNA SIX3OS1 in acute stroke and PSCI aiming to identify a novel biomarker.

PATIENTS AND METHODS

The study enrolled 138 patients with acute stroke and 80 healthy individuals. By comparing the serum SIX3OS1 in acute stroke and healthy individuals, the significance of SIX3OS1 in diagnosing acute stroke, assessing disease severity, and predicting the risk of PSCI was revealed.

RESULTS

Significant upregulation of SIX3OS1 in acute stroke was observed, which discriminated patients with acute stroke from healthy individuals and indicated severe disease conditions of patients. There were 72 acute stroke patients who had PSCI accounting for 52.17% that showed a higher serum SIX3OS1 level than post-stroke cognitive normal patients. The increasing serum SIX3OS1 level was also identified as a risk factor for PSCI and could distinguish PSCI patients. Additionally, SIX3OS1 showed a negative correlation with the MoCA score of PSCI patients.

CONCLUSION

Serum SIX3OS1 level can be considered a biomarker for screening acute stroke and a predictor for PSCI.

摘要

背景

中风是死亡和残疾的主要原因。中风后认知障碍(PSCI)是中风最严重的并发症之一,缺乏用于早期检测的有效生物标志物。

目的

本研究评估lncRNA SIX3OS1在急性中风和PSCI中的意义,旨在确定一种新的生物标志物。

患者与方法

本研究纳入138例急性中风患者和80名健康个体。通过比较急性中风患者和健康个体的血清SIX3OS1,揭示SIX3OS1在诊断急性中风、评估疾病严重程度和预测PSCI风险中的意义。

结果

观察到急性中风患者血清SIX3OS1显著上调,这可将急性中风患者与健康个体区分开来,并提示患者的病情严重。72例急性中风患者发生PSCI,占52.17%,其血清SIX3OS1水平高于中风后认知正常的患者。血清SIX3OS1水平升高也被确定为PSCI的一个危险因素,并且可以区分PSCI患者。此外,SIX3OS1与PSCI患者的MoCA评分呈负相关。

结论

血清SIX3OS1水平可被视为筛查急性中风的生物标志物和PSCI的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4117/11670514/32749be4460c/12883_2024_4003_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4117/11670514/67314c6d001a/12883_2024_4003_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4117/11670514/32749be4460c/12883_2024_4003_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4117/11670514/67314c6d001a/12883_2024_4003_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4117/11670514/32749be4460c/12883_2024_4003_Fig2_HTML.jpg

相似文献

1
lncRNA six3os1 diagnoses acute stroke, predicts disease severity, and predicts post-stroke cognitive impairment.长链非编码RNA six3os1可诊断急性中风,预测疾病严重程度,并预测中风后认知障碍。
BMC Neurol. 2024 Dec 26;24(1):491. doi: 10.1186/s12883-024-04003-5.
2
Silencing lncRNA SIX3OS1 mitigates inflammation and apoptosis in post-stroke cognitive impairment via miR-511-3p.沉默长链非编码 RNA SIX3OS1 通过 miR-511-3p 减轻卒中后认知障碍中的炎症和细胞凋亡。
Gen Physiol Biophys. 2024 Nov;43(6):567-576. doi: 10.4149/gpb_2024035.
3
Serum neurofilament heavy chain predicts post-stroke cognitive impairment.血清神经丝轻链可预测中风后认知障碍。
Sci Rep. 2025 Apr 19;15(1):13556. doi: 10.1038/s41598-025-96952-1.
4
Exploring the Relationship Between Serum Neuronal Pentraxin 2 and Poststroke Cognitive Impairment in Patients With First-Episode Acute Ischemic Stroke.探索首次发作急性缺血性脑卒中患者血清神经元五聚体蛋白2与卒中后认知障碍之间的关系。
Brain Behav. 2025 Feb;15(2):e70305. doi: 10.1002/brb3.70305.
5
Serum Galectin-3 as a Potential Predictive Biomarker Is Associated with Poststroke Cognitive Impairment.血清半乳糖凝集素-3 作为一种潜在的预测生物标志物与卒中后认知障碍相关。
Oxid Med Cell Longev. 2021 Dec 2;2021:5827812. doi: 10.1155/2021/5827812. eCollection 2021.
6
The association between serum uric acid level and the risk of cognitive impairment after ischemic stroke.血清尿酸水平与缺血性脑卒中后认知障碍风险的关系。
Neurosci Lett. 2020 Aug 24;734:135098. doi: 10.1016/j.neulet.2020.135098. Epub 2020 May 30.
7
Blood biomarkers for post-stroke cognitive impairment: A systematic review and meta-analysis.卒中后认知障碍的血液生物标志物:系统评价和荟萃分析。
J Stroke Cerebrovasc Dis. 2024 Aug;33(8):107632. doi: 10.1016/j.jstrokecerebrovasdis.2024.107632. Epub 2024 Feb 28.
8
Serum Retinoic Acid Level and The Risk of Poststroke Cognitive Impairment in Ischemic Stroke Patients.血清维甲酸水平与缺血性脑卒中患者卒中后认知障碍的风险。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104352. doi: 10.1016/j.jstrokecerebrovasdis.2019.104352. Epub 2019 Sep 6.
9
Circulating HMGB1 in acute ischemic stroke and its association with post-stroke cognitive impairment.急性缺血性脑卒中患者循环 HMGB1 及其与卒中后认知障碍的关系。
PeerJ. 2024 Apr 30;12:e17309. doi: 10.7717/peerj.17309. eCollection 2024.
10
Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months.开发并验证一种用于卒中后 6 个月认知障碍的临床模型(DREAM-LDL)。
Aging (Albany NY). 2021 Sep 10;13(17):21628-21641. doi: 10.18632/aging.203507.

本文引用的文献

1
LncRNA MALAT1 and Ischemic Stroke: Pathogenesis and Opportunities.长链非编码 RNA MALAT1 与缺血性脑卒中:发病机制与机遇。
Mol Neurobiol. 2024 Jul;61(7):4369-4380. doi: 10.1007/s12035-023-03853-3. Epub 2023 Dec 12.
2
Geniposide improves depression by promoting the expression of synapse-related proteins through the Creb1/Six3os1 axis.京尼平苷通过Creb1/Six3os1轴促进突触相关蛋白的表达来改善抑郁症。
Gene. 2023 Aug 15;877:147564. doi: 10.1016/j.gene.2023.147564. Epub 2023 Jun 11.
3
Early post-stroke cognitive impairment and in-hospital predicting factors among stroke survivors in Ethiopia.
埃塞俄比亚中风幸存者的早期中风后认知障碍及院内预测因素
Front Neurol. 2023 May 22;14:1163812. doi: 10.3389/fneur.2023.1163812. eCollection 2023.
4
Which cutoff value of the Montreal Cognitive Assessment should be used for post-stroke cognitive impairment? A systematic review and meta-analysis on diagnostic test accuracy.用于诊断脑卒中后认知障碍的蒙特利尔认知评估的截断值是多少?一项关于诊断准确性的系统评价和荟萃分析。
Int J Stroke. 2023 Oct;18(8):908-916. doi: 10.1177/17474930231178660.
5
Research on Diagnostic Markers for Post-Stroke Cognitive Impairment.
Altern Ther Health Med. 2023 Apr;29(3):230-235.
6
Effects on Autophagy of Moxibustion at Governor Vessel Acupoints in APP/PS1double-Transgenic Alzheimer's Disease Mice through the lncRNA Six3os1/miR-511-3p/AKT3 Molecular Axis.基于lncRNA Six3os1/miR-511-3p/AKT3分子轴探讨督脉穴位艾灸对APP/PS1双转基因阿尔茨海默病小鼠自噬的影响
Evid Based Complement Alternat Med. 2022 Oct 5;2022:3881962. doi: 10.1155/2022/3881962. eCollection 2022.
7
Association between diabetes mellitus and post-stroke cognitive impairment.糖尿病与脑卒中后认知障碍的关系。
J Diabetes Investig. 2023 Jan;14(1):6-11. doi: 10.1111/jdi.13914. Epub 2022 Oct 1.
8
Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview.用于阿尔茨海默病诊断和进展的基于血液的生物标志物:概述。
Cells. 2022 Apr 17;11(8):1367. doi: 10.3390/cells11081367.
9
Post-Stroke Cognitive Impairment and Dementia.卒中后认知障碍和痴呆。
Circ Res. 2022 Apr 15;130(8):1252-1271. doi: 10.1161/CIRCRESAHA.122.319951. Epub 2022 Apr 14.
10
Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.卒中后认知障碍:流行病学、危险因素和管理。
J Alzheimers Dis. 2022;86(3):983-999. doi: 10.3233/JAD-215644.